தகவல்கள் பாதுகாப்பு கண்காணிப்பு குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தகவல்கள் பாதுகாப்பு கண்காணிப்பு குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தகவல்கள் பாதுகாப்பு கண்காணிப்பு குழு Today - Breaking & Trending Today

Cardiol Therapeutics Inc is commercializing its THC-free cannabidiol formulation to treat heart disease


Proprietary formulation produces ultra-pure pharmaceutical cannabidiol (CBD) without the psychotropic effects of THC for the treatment of inflammatory heart disease
Received US FDA approval to commence a Phase II/III COVID-19 trial investigating the cardioprotective properties of CardiolRx
Has launched Cortalex through a national agreement with Medical Cannabis by Shoppers to retail it on an exclusive basis across Canada
Cardiol Therapeutics Inc (TSE:CRDL) (OTCQX:CRTPF) is a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease.
The Canadian specialty pharmaceutical company has developed a proprietary formula of ultra-pure pharmaceutical cannabidiol (CBD) that does not contain THC - less than 5 parts per million (ppm) - and consequently none of the psychotropic effects of THC. ....

United States , Douglas Loe , Leede Jones Gable , Andrew Hamer , David Elsley , Cardiometabolic At Amgen Inc , Data Safety Monitoring Committee , Global Development , Dalton Pharma Services , Drug Administration , Clinical Endpoint Committee , Toronto Stock Exchange , Completion Of Health Canada , Medical Cannabis , North America , Executive Director , Global Development Cardiometabolic , Amgen Inc , Toronto Stock , Health Canada , Speculative Buy , Deep Dive , Harma Biotech , Cardiol Therapeutics , Tse Crdl , ஒன்றுபட்டது மாநிலங்களில் ,